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1 |  INTRODUCTION
The cohesion complex is a ring- like chromatin- associated 
multi- subunit complex, highly conserved during evolution, 
mainly involved in sister chromatid cohesion but also in 
chromosome segregation, maintenance of genome stability, 
transcriptional regulation, chromatin structure, 3D genome 
organization, and DNA double- strand break repair (Barbero, 
2013; Watrin et al., 2016). Indeed, being an essential compo-
nent of the family of modulators of chromatin structure, it is 
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Abstract
Background: Cornelia de Lange syndrome (CdLS) is a rare and clinically variable 
syndrome characterized by growth impairment, multi- organ anomalies, and a typical 
set of facial dysmorphisms. Here we describe a 2- year- old female child harboring a 
novel de novo missense variant in HDAC8, whose phenotypical score, according to 
the recent consensus on CdLS clinical diagnostic criteria, allowed the diagnosis of a 
non- classic CdLS.
Methods: Clinical exome sequencing was performed on the trio, identifying a de 
novo heterozygous variant in HDAC8 (NM_018486; c. 356C>G p.Thr119Arg). 
Molecular modeling was performed to evaluate putative functional consequence of 
the HDAC8 protein.
Results: The variant HDAC8 c.356C>G is classified as pathogenic following the 
ACMG (American College of Medical Genetics and Genomics)/AMP (Association 
for Molecular Pathology) guidelines. By molecular modeling, we confirmed the del-
eterious effect of this variant, since the amino acid change compromises the confor-
mational flexibility of the HDAC8 loop required for optimal catalytic function.
Conclusion: We described a novel Thr119Arg mutation in HDAC8 in a patient dis-
playing the major phenotypic traits of the CdLS. Our results suggest that a mod-
est change outside an active site is capable of triggering global structural changes 
that propagate through the protein scaffold to the catalytic site, creating de facto 
haploinsufficiency.
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not surprising that defects in the cohesin complex or its reg-
ulators are associated to genetic instability syndromes, now 
called cohesinopathies (Sarogni et al., 2020).
Among these syndromes, the best defined is the Cornelia 
de Lange syndrome (CdLS), a multisystem malformation 
condition that due to its wide clinical variability includes five 
subtypes (OMIM #122470, # 300590, # 610759, # 614701, 
and # 300882), with either severe or milder phenotypes.
CdLS is a rare condition with a prevalence of 1/30’000 
to 1/10’000 live births that is recognized primarily on the 
basis of characteristic facial dysmorphism and microcephaly, 
in association with prenatal and postnatal growth retarda-
tion, intellectual disability, and, in many cases, upper limb 
anomalies (Kline et al., 2018). CdLS display a huge clini-
cal variability, with a wide spectrum of phenotypes ranging 
from mild to severe, with different degrees of facial and limb 
abnormalities even in the presence of variants affecting the 
same causative gene (Aoi et al., 2019; Avagliano et al., 2020).
Mutations in NIPBL (65%), SMC1A (5%), SMC3 (<1%), 
RAD21 (<1%), and  HDAC8  (4%) collectively account for 
about 75% of individuals with clinically diagnosed CdLS.
Heterozygous mutations in NIPBL,  RAD21, 
and  SMC3  are usually transmitted in an autosomal domi-
nant manner, while heterozygous or hemizygous mutations 
in SMC1A and HDAC8 have a X- linked related transmission 
(Infante et al., 2017). Most cases of CdLS are de novo (99%), 
with rare reports of inherited CdLS within families, but also 
cases of somatic mosaicism have been described (Barbero, 
2013).
To date, 48 unique deleterious variants have been reported 
in HDAC8. It encodes for a class I metal- dependent histone 
deacetylase that deacetylates SMC3 during S- phase to facil-
itate renewal of the cohesin complex after its dissociation 
from chromatin (Mannini et al., 2013).
Here, we report a patient with typical CdLS harboring a 
previously unreported de novo HDAC8 missense mutation, 
which was identified by trio- based exome sequencing.
2 |  MATERIAL AND METHODS
2.1 | Editorial policies and ethical 
considerations
Informed consent was obtained from all individuals included 
in the study.
2.2 | Sample collection and whole- exome 
sequencing (WES)
Genomic DNA was isolated from peripheral blood using 
the QIAsymphony DSP DNA Mini Kit (Qiagen, Hilden, 
Germany) following manufacturer's instructions. Library 
preparation and clinical exome capture were performed 
using the Twist Custom Panel kit (Twist Bioscience, San 
Francisco, CA, USA) and sequenced on the NovaSeq 6000 
platform (Illumina). The BaseSpace pipeline (Illumina) and 
the TGex software (LifeMap Sciences) were used for vari-
ant calling and annotation. Reads were aligned to human ge-
nome build GRCh37/hg19. Based on the guidelines of the 
American College of Medical Genetics and Genomics and 
the Association for Molecular Pathology (ACMG/AMP), a 
minimum depth coverage of 20X was considered suitable for 
analysis. The mean coverage for the target region was 152X.
2.3 | Homology modeling and molecular 
dynamic simulations
Molecular modeling and molecular dynamics simulations 
were performed as previously described (Mio et al., 2020). 
Briefly, the structure of the wild- type HDAC8 was taken from 
the Protein Data Bank (www.rcsb.org). The entry with PDB 
id. 1t64 was chosen according to literature (Somoza et al., 
2004). All ligands except Zn were removed and only chain 
A was considered. A model of the Thr119Arg mutant was 
obtained using the software Scwrl4 (Krivov et al., 2009) and 
keeping all residues different from the mutated one fixed in 
order not to modify the catalytic site. The resulting structure 
was soaked in a box of water and 0.150 M NaCl up to at least 
14 A from any solute atom. The distance of the catalytic Zn 
from the coordinating atoms of the protein was restrained by 
a harmonic potential with a force constant equal to 400 kcal/
mol A. All molecular simulations were performed using 
the program NAMD (Phillips et al., 2005). The structure 
was energy minimized in 5000 steps, heated to 310 K, and 
equilibrated at the same temperature for 1 ns. Then, 100 ns 
molecular dynamics was simulated by keeping pressure at 
1 atm by a Langevin piston and keeping the temperature at 
310 K by Langevin dynamics. The cutoff employed for non- 
bonded interactions was 12 A, switching at 10 A and keep-
ing track of all atoms within 14 A. The time step was 1 fs 
for bonded interactions and 2 fs for non- bonded interactions. 
Hydrogen bond lengths were restrained by the algorithm set-
tle. All details and relevant literature are provided in the user 
guide of the program NAMD (http://www.ks.uiuc.edu/Resea 
rch/namd/cvs/ug.pdf). Exactly the same protocol was applied 
to the wild- type and mutant protein.
3 |  RESULTS
The proposita is a 2- year- old Caucasian female referred to 
our Medical Genetics Institute for genetic counseling in the 
context of facial dysmorphisms, short hands and feet, mild 
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T A B L E  1  Detailed phenotypical features of our propositaa
Clinical characteristics HPO identifier HDAC8+/− Proposita
Growth
Intrauterine growth retardation (IUGR) HP:0001511 50– 70% Yes
weight below 5th percentile for age HP:0004325 20– 40% Yes
height or length below 5th percentile for age HP:0004322 Yes
Dysmorphic features
Brachycephaly HP:0001626 70% Yes
Microcephaly HP:0000252 29% Yes
Low anterior hairline HP:0000294 67% Yes
Arched eyebrows HP:0002553 88% Yes
Synophrys HP:0000664 ≥90% Yes
Long eyelashes HP:0000527 45% Yes
Telecanthus and/or hypertelorism HP:0000506, HP:0000316 64% Yes
Depressed nasal bridge HP:0005280 45% No
Anteverted nostrils HP:0000463 76% No
Long philtrum HP:0000319 57% No
Smooth philtrum HP:0000319 30% Yes
Thin upper vermilion lip HP:0000219 20– 50% No
Downturned corners of the mouth HP:0002714 57% No
Highly arched palate HP:0000218 20– 50% Yes
Small widely spaced teeth HP:0000687 61% Yes
Micrognathia/retrognathia HP:0000347, HP:0000278 59% No
Low- set and/or malformed ears HP:0000369, HP:0000377 20– 50% Yes
Short neck HP:0000470 48% Yes
Trunk and limb abnormalities
Oligodactyly and adactyly (hands) HP:0012165, HP:0009776 44% No
Small hands and/or feet HP:0200055, HP:0001773 ≥90% Yes
Proximally placed thumbs HP:0009623 70– 90% No
5th finger clinodactyly HP:0004209 50% No
Short 5th finger HP:0009237 84% Yes
Neurosensory– Skin defects
Ocular defects HP:0000478 40– 60% Yes
Deafness or hearing loss HP:0000365 59% Yes
Hirsutism HP:0001007 65% No
Nevus flammeus HP:0001052 58% Yes
Development
Developmental delay HP:0001263 90% Yes
Intellectual disability HP:0001249 100% Yes
Other
Gastroesophageal reflux HP:0002020 44% NA
Feeding difficulties in infancy HP:0011968 67% Yes
Genitourinary anomalies HP:0000119 36% No
Cardiovascular anomalies HP:0001626 40% Yes
Behavior abnormalities HP:0000708 20– 50% NA
aBased on Gao et al. (2018), Kaiser et al. (2014), Kline et al. (2018). 
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limb hypertonia, cutaneous hemangiomas, and pulmonary 
valve dysplasia. She is the second- born child of healthy 
non- consanguineous parents. Family history was unre-
markable. During prenatal screening, intrauterine growth 
restriction (IUGR), oligohydramnios, and decreased fetal 
movements (DFMs) were observed. C- section was performed 
at 39 + 5 weeks of gestation. Birth weight was 2440 g (−2.5 
SD), occipitofrontal circumference was 32 cm (−3 SD), and 
birth length was 45 cm (−3 SD). General physical examina-
tion showed full- blown dysmorphic features: brachycephaly, 
low anterior hairline, arched eyebrows with synophrys, long 
eyelashes, broad nasal tip, smooth philtrum, and low- set ears 
F I G U R E  1  Phenotypic and genotypic characteristics of the proposita. (a) Facial dysmorphisms: low anterior hairline, arched eyebrows, 
hypertelorism, broad nasal tip, smooth philtrum, low- set ears, widely spaced teeth, and thin upper lip; (b) Small hand with short fifth finger; c, NGS 
trio- based analysis showing the de novo HDAC8 (NM_018486) variant c.356C>G
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with overfolded helices of the left ear. She, also, presented a 
high- arched palate, facial midline hemangioma, short neck, 
small hands and feet, pulmonary valve dysplasia, a low- 
pitched growling cry, and developmental delay. Furthermore, 
infant audiological screening highlighted a congenital senso-
rineural hearing impairment. At 20 months, she was unable 
to sit without support, suggesting psychomotor development 
delay. Ophthalmologic evaluation disclosed visual impair-
ment and myopia. Detailed clinical characteristics are en-
listed in Table 1.
Since the proposita's phenotype was suggestive of the 
CdLS (Figure 1a,b), clinical exome sequencing was per-
formed on the trio, identifying a de novo heterozygous mis-
sense variant in the HDAC8 gene (NM_018486) c. 356C>G 
(p.Thr119Arg) (Figure 1c). This variant is absent from the 
major population databases and results in a non- conservative 
amino acid change located in the functional domain of the 
encoded protein. The substitution is never been reported and 
it is predicted as having a deleterious effect by multiple com-
putational algorithms (15 of 17). Moreover, a C>T transition 
has been described on the same nucleotide by Yuan and col-
leagues (Yuan et al., 2015) and associated to CdLS. Based 
on the evidence outlined above and following the ACMG 
guidelines (Richards et al., 2015), the variant is classified as 
pathogenic (PS2, PM1, PM2, PP2, and PP3). We annotated 
the clinical classification for this alteration in the ClinVar da-
tabase (RCV001268970).
Relying on this, to assess the putative molecular conse-
quences of the p.Thr119Arg substitution in HDAC8 amino 
acid sequence, molecular modeling was performed. Position 
119 is located within one of the helices that participate in the 
three- layer α- β- α domain, which spans the majority of the 
protein structure. The sequence, and in particular Thr119, is 
completely conserved from humans to frogs (Figure 2a).
F I G U R E  2  Sequence analysis and homology modeling of the HDAC8 mutant. (a) Partial protein alignment (aa 96– 115) showing the 
conservation of the Thr119 residue (highlighted in red). (b) Residue 119 is shown as van der Waals spheres, the residues defining the binding and 
catalytic cavity are shown in licorice, and the zinc atom is shown as a yellow sphere. The position where Arg119 contacts the residue 140 adjacent 
to binding pocket residue is highlighted by a red circle
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The superposition of the secondary structure elements of 
the wild- type and mutant protein after minimization resulted 
in an RMSD of 0.4 A, showing no substantial rearrangement 
in the three- layer alpha- beta- alpha fold. Indeed, notwith-
standing the largely different volumes of the two residues and 
the inner position of position 119, the mutation did not result 
in very severe steric hindrance. The snapshots taken from the 
molecular dynamics simulation runs were superimposed on 
the starting structure to check the structural variations along 
the trajectory. For both wild- type and mutant, the average 
RMSD on the secondary structure elements was below 1.0 
A, showing a rather stable arrangement on this timescale.
Although it is reasonable to expect that a buried charged 
residue like arginine would destabilize the folded form, in the 
simulations, the same residue establishes a salt bridge with 
Asp157. Twenty snapshots along the trajectory were super-
imposed onto each other using secondary structure elements 
and the RMSD of the Cα atoms of each residue was recorded 
and averaged. This procedure gave the RMSF at each residue. 
This was done for both proteins, and finally the snapshots 
from the wild- type trajectory were superimposed in a similar 
fashion with those of the mutant trajectory.
The comparison of the within- trajectory RMSFs with the 
between- trajectory RMSFs highlighted the regions where the 
average RMSDs could not be justified by local fluctuations, 
that is, the two trajectories display fluctuations about differ-
ent average conformations. The largest effect was observed at 
residues 138– 140. This stretch of residues is adjacent to the 
residues 142– 143 defining the catalytic pocket of the enzyme 
(Figure 2b).
4 |  DISCUSSION
The CdLS is a both genotypically and phenotypically het-
erogeneous disorder characterized by a core of dysmorphic 
features together with intellectual disability, growth delay, 
hirsutism, and limb defects. A recent consensus of a group 
of international experts has been made on clinical diagnostic 
criteria and molecular investigations (Kline et al., 2018). Our 
proposita's phenotype reached a score of 10, allowing the di-
agnosis of a non- classic CdLS (Table 2).
To uncover the molecular defect underlying the patient's 
phenotype, a trio- based NGS approach was performed, high-
lighting a de novo heterozygous missense variant in HDAC8. 
HDAC8 (OMIM #300269) is located on chromosome Xq13.1 
and it encodes for a class I histone deacetylase that deacetyl-
ates SMC3 during S- phase to establish the proper dissolution 
of pro- cohesive elements and, consequently, the establish-
ment of a new functional complex (Mannini et al., 2013). To 
Phenotypical feature HPO identifier Proposita
Cardinala 
Synophrys and/or arched eyebrows HP:0000664, HP:0000574 Yes





Long and or smooth philtrum HP:0000343, HP:0000319 Yes
Thin upper lip vermilion and/or 
downturned corners of mouth
HP:0000219, HP:0002714 No
Hand oligodactyly and/or adactyly HP:0001180, HP:0009776 No
Congenital diaphragmatic hernia HP:0000776 No
Suggestivea 
Prenatal growth restriction (<2 SD) HP:0001511 Yes
Postnatal growth retardation (<2 SD) HP:0008897 Yes




Small hands and/or feet HP:0200055, HP:0001773 Yes
Short fifth finger HP:0009237 Yes
Hirsutism HP:0001007 No
Clinical scoreb 10
aCardinal features are individually scored with 2 points; suggestive features are individually scored with 1 
point. 
b≥11 points (at least three cardinal): classic CdLS; 9 or 10 points (at least two cardinal): non- classic CdLS; 4– 8 
points (at least one cardinal): molecular testing required; <4 points: insufficient evidence for molecular testing. 
Following the recommendations in Kline et al. (2018). 
T A B L E  2  Clinical scoring for the 
diagnosis of Cornelia de Lange syndrome
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date, more than 60 patients harboring a unique HDAC8 mu-
tation and showing cardinal features of the CdLS have been 
reported (Gao et al., 2018; Jezela- Stanek et al., 2019).
Patients with HDAC8 variants often not only show a CdLS 
phenotype, but also distinct features such as hypertelorism, a 
broad or bulbous nasal tip, hooding of eyelids, late closure of 
the anterior fontanelle, teeth anomalies, and mosaic patches 
of skin pigmentation. Moreover, it is already established that 
the severity of clinical phenotypes caused by HDAC8 muta-
tions is heavily influenced by random X- inactivation in fe-
males (Kaiser et al., 2014).
Indeed, males are mostly severely affected, while fe-
males, who represent more than 70% of the patients (Parenti 
et al., 2016), display diversified phenotypes whose variability 
would be related to the extent of the tissue- specific skewed 
lyonization (Parenti et al., 2016). Relying on this, it was not 
surprising that our proposita displayed a non- classical CdLS.
To shed light on the molecular consequences underlying 
the identified mutation, homology modeling and molecular 
dynamics were performed. The mutation Thr119Arg is ac-
commodated with small structural rearrangements, some-
thing which was not anticipated based on the largely different 
volume of the two amino acids and the internal position of 
the residue. It is likely that the mutation destabilizes the 
folded form due to a large entropic contribution associated 
with restrictions in conformational mobility. Arg119 is able 
to establish a favorable ionic interaction with Asp157 likely 
to balance desolvation free energy. The contact between 
Arg119 and the region 138– 140 leads to structural sizeable 
differences. The region is located in one of the loops defining 
the substrate binding pocket. This suggests that the mutation 
can alter the binding of the substrate and, consequently, the 
catalytic efficiency of the protein. The effects observed are 
similar to those described by Decroos and colleagues regard-
ing the p.Gly117Glu replacement, which compromises the 
conformational flexibility of the HDAC8 loop required for 
optimal catalytic function by triggering structural changes 
propagating through the protein scaffolding to the aforemen-
tioned loop. This substitution, in fact, resulted in a 5% resid-
ual enzyme activity (Decroos et al., 2015).
In summary, we described a novel Thr119Arg mutation in 
HDAC8 in a patient displaying the chief phenotypical char-
acteristics of the CdLS, that is, brachycephaly, low anterior 
hairline, arched eyebrows with synophrys, long eyelashes, 
broad nasal tip, smooth philtrum, low- set ears, short neck, 
small hands and feet, and a low- pitched growling cry and de-
velopmental delay. Our computational data suggest that the 
amino acid change triggers a structural change that alters the 
substrate binging capability of the protein.
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